Article info

Extended report
Efficacy of tocilizumab in patients with moderate to severe active rheumatoid arthritis and a previous inadequate response to disease-modifying antirheumatic drugs: the ROSE study

Authors

  1. Correspondence to Dr Yusuf Yazici NYU Hospital for Joint Diseases, 246 East 20th Street, NY 10003, USA; yusuf.yazici{at}nyumc.org
View Full Text

Citation

Yazici Y, Curtis JR, Ince A, et al
Efficacy of tocilizumab in patients with moderate to severe active rheumatoid arthritis and a previous inadequate response to disease-modifying antirheumatic drugs: the ROSE study

Publication history

  • Accepted August 3, 2011
  • First published September 26, 2011.
Online issue publication 
December 28, 2011

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.